NetScientific plc
("NetScientific", the "Group" or the "Company")
Result of Annual General Meeting
Change of name of Nominated Adviser and Broker
NetScientific Plc (AIM: NSCI), the deep tech and life sciences VC investment group, announces that all resolutions set out in the 2024 Notice of Annual General Meeting sent to shareholders were duly passed at the Company's Annual General Meeting held earlier today.
Result of Annual General Meeting
Resolutions 1 to 6 were passed as Ordinary Resolutions and Resolution 7 was passed as a Special Resolution. The proxy voting results are as follows:
|
Resolution |
For |
% |
Against |
% |
Vote Total |
Vote Total as % of Issued Share Capital |
Withheld* |
|
1. To receive and adopt the Company's Annual Report and Accounts for the period ended 31 December 2023
|
5,242,260
|
100.0%
|
0
|
0.0%
|
5,242,260
|
21.9%
|
0
|
|
2. To receive and approve the Directors' Remuneration Report
|
5,199,678
|
99.2%
|
42,570
|
0.8%
|
5,242,248
|
21.9%
|
12
|
|
3. To reappoint BDO LLP as the auditors for the forthcoming year
|
5,236,319
|
99.9%
|
5,941
|
0.1%
|
5,242,260
|
21.9%
|
0
|
|
4. To authorise the Audit Committee in determining the Auditors' remuneration
|
5,242,260
|
100.0%
|
0
|
0.0%
|
5,242,260
|
21.9%
|
0
|
|
5. To confirm the reappointment of Dr Ilian Iliev as a director
|
5,237,162
|
99.9%
|
5,098
|
0.1%
|
5,242,260
|
21.9%
|
0
|
|
6. To authorise the Directors to allot relevant securities pursuant to section 551 of the Companies Act 2006
|
5,135,560
|
98.2%
|
92,634
|
1.8%
|
5,228,194
|
21.8%
|
14,066
|
|
7. To disapply pre-emption rights on the allotment of securities or sale of treasury shares in connection with a pre-emptive offer or on allotment of up to 239,458 shares
|
5,067,937
|
96.9%
|
160,257
|
3.1%
|
5,228,194
|
21.8%
|
14,066
|
* A vote withheld is not a vote in law and is not counted in the calculation of the proportion of votes "For" or "Against" a resolution.
Change of Name of Nominated Adviser and Broker
The Company also announces that its Nominated Adviser and Broker has changed its name to Panmure Liberum Limited following completion of its own corporate merger.
For more information, please contact:
|
NetScientific |
|
|
Ilian Iliev, CEO |
Via Belvedere Communications |
|
|
|
|
Panmure Gordon ( |
|
|
Emma Earl / Will Goode / Freddy Crossley / Mark Rogers (Corporate Finance) Rupert Dearden (Corporate Broking) |
+44 (0)20 7886 2500 |
|
|
|
|
Belvedere Communications John West / Llewellyn Angus / Lily Pearce |
+44 (0)20 7653 8702 |
About NetScientific
NetScientific plc (AIM: NSCI) is a deep tech and life sciences VC investment group with an international portfolio of innovative companies.
NetScientific identifies, invests in, and builds high growth companies in the
The company adds value through the proactive management of its portfolio, progressing to key value inflection points, and delivering investment returns through partial or full liquidity events.
NetScientific differentiates itself by employing a capital-efficient investment approach, making judicial use of its balance sheet and syndicating investments through its wholly owned VC subsidiary, EMV Capital. The group secures a mixture of direct equity stakes and carried interest stakes in its portfolio of companies, creating a lean structure that can support a large portfolio.
NetScientific is headquartered in
www.netscientific.net www.netscientific.net
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.